Stephanie Graff: The relationship of PIM1 and metastatic breast cancer, potential therapeutic implications with CDK4/6 inhibitors and more!

Quoting Stephanie Graff on LinkedIn:

”That’s a wrap on the 2023 European Society of Medical Oncology Congress in Madrid, Spain. I was able to present a project that I collaborated on with Legorreta Cancer Center clinician-scientist Dr. Sheldon Holder and Caris Life Sciences, pictured here with data scientist Andrew Elliot. We describe the relationship of PIM1 and metastatic breast cancer outcome, as well as potential therapeutic implications with CDK4/6 inhibitors and more!”

Source: Stephanie Graff/LinkedIn

Stephanie L. Graff is the Director of the Breast Oncology Program at Lifespan Cancer Institute and co-leader of the Breast Cancer Translational Research Disease Group. She also serves as a medical advisor to the Dr. Susan Love Foundation for Breast Cancer Research, is an Associate Editor of Cancer Medicine, and chairs the editorial board of Oncology Times. Dr. Graff is a leader on social media and a sought-after public speaker.